Skip to main content
Premium Trial:

Request an Annual Quote

Following Reverse Merger with Xtrana, Alpha Innotech Trades on OTCBB

NEW YORK, Oct. 10 (GenomeWeb News) - Alpha Innotech and Xtrana have closed a reverse merger, the companies said last week.


The merged company changed its name to Alpha Innotech and began trading on the NASD over-the-counter bulletin board under the new name last week, following a one-for-ten reverse stock split.


Alpha Innotech shareholders and Xtrana stockholders approved the merger earlier this month. All outstanding capital stock of Alpha Innotech, which was privately held prior to the merger, was converted into the right to receive shares of Xtrana common stock.


Alpha Innotech, based in San Leandro, Calif., provides digital imaging and detection system for life science research. The company combines instruments, reagents, and bioinformatics software to offer integrated technology platforms for electrophoresis, functional genomics, proteomics, and cell analysis. The company had $10.5 million in revenues last year.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.